Letters
Careless talk may cost lives in attributing adverse events to ADP receptor antagonists
BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7344.1039 (Published 27 April 2002) Cite this as: BMJ 2002;324:1039
- Michael J Green (drmjgreen@hotmail.com), specialist registrar rheumatology,
- Martin Iveson, consultant rheumatologist,
- Robert Crook, consultant cardiologist and general physician,
- Nichola Burrows, senior house officer,
- Andrew KS Gough, consultant rheumatologist
- York District Hospital, Wigginton Lane, York YO31 8HE
- Harrogate District Hospital, Harrogate HG2 7SX
EDITOR—Dakik et al in their article suggest an association between the prescription of an ADP receptor antagonist (ticlodipine) with the onset of acute arthritis.1 We would like to express a note of caution. This article follows a previous one discussing another ADP receptor antagonist (clopidogrel) and the development of acute arthritis.2 These drugs are increasingly used in combination with aspirin for the prevention of thrombosis after coronary artery stenting and have been shown to be safe and efficacious. 3 4 It is …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.